Mianserin vs. amitriptyline--a double-blind-trial evaluated by the AMP-system
Vogel, H.P.; Bente, D.; Feder, J.; Helmchen, H.; Müller-Oerlinghausen, B.; Bohacek, N.; Mihovilovic, M.; Brändle, A.; Fleischhauer, J.; Walcher, W.
Activitas Nervosa Superior 17(4): 229-230
1975
ISSN/ISBN: 0001-7604 PMID: 769477 Document Number: 89462
Document emailed within 1 workday
Related Documents
Montgomery, S.A.; Mcauley, R.; Montgomery, D.B.; Dawling, S.; Braithwaite, R.A. 1980: Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial Clinical Therapeutics 3(4): 292-310Lennox, I.G.; Asbury, J.F.; Couldrick, W.G.; Beswick, K.B. 1978: Viloxazine and amitriptyline in depressive illness. a double blind controlled trial in general practice Practitioner 220(1315): 153-156
Casacchia, M.; Cerbo, R.; Corona, R.; Boni, B. 1981: Double-blind study of the effects of amitriptyline and of a combination of amitriptyline and lithium on patients with chronic primary headache Rivista di Neurologia 51(2): 114-123
Condon, R.E.; Munshi, C.A.; Arfman, R.C. 1995: Interaction of vecuronium with piperacillin or cefoxitin evaluated in a prospective, randomized, double-blind clinical trial American Surgeon 61(5): 403-406
Pfaffenrath, V.; Diener, H.C.; Isler, H.; Meyer, C.; Scholz, E.; Taneri, Z.; Wessely, P.; Zaiser-Kaschel, H.; Haase, W.; Fischer, W. 1993: Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo Der Nervenarzt 64(2): 114-120
Rapisarda, V.; Bongiorno, G. 1982: Double blind test with mianserin versus chlorimipramine Advances in Biochemical Psychopharmacology 32: 141-149
McLean, P.C.; Ancill, R.J.; Szulecka, T.K. 1986: Mianserin in the treatment of depressive symptoms in alcoholics. a double-blind placebo controlled study using a computer delivered self-rating scale Psychiatria Polska 20(6): 417-427
Biesbroeck, R.; Bril, V.; Hollander, P.; Kabadi, U.; Schwartz, S.; Singh, S.P.; Ward, W.K.; Bernstein, J.E. 1995: A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy Advances in Therapy 12(2): 111-120
Reimherr, F.W.; Chouinard, G.; Cohn, C.K.; Cole, J.O.; Itil, T.M.; LaPierre, Y.D.; Masco, H.L.; Mendels, J. 1990: Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression Journal of Clinical Psychiatry 51 Suppl B: 18-27
Spear, S.L.; Matsuba, H.; Romm, S.; Little, J.W. 1991: Methyl prednisolone in double-lumen gel-saline submuscular mammary prostheses: a double-blind, prospective, controlled clinical trial Plastic and Reconstructive Surgery 87(3): 483-487; Discussion: 488-489
Gratzke, P.; Kirby, R.S. 2000: Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability Fortschritte der Medizin. Originalien 118(Suppl 2): 83-92
Bruynooghe, F.; Geerts, S.; van Maele, G.; Vögtle-Junkert, U. 1992: Treatment of reactive depression with sulpiride. Double-blind study with sulpiride and amitriptyline in an interindividual comparison Fortschritte der Medizin 110(27): 498-502
Mantero, J.C.; Kishore, N.; Ziemek, J.; Stifano, G.; Zammitti, C.; Khanna, D.; Gordon, J.K.; Spiera, R.; Zhang, Y.; Simms, R.W.; Lafyatis, R. 2018: Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. a phase I/Ii biomarker trial Clinical and Experimental Rheumatology 36 Suppl 113(4): 146-149
Bieber, T.; Chosidow, O.; Bodsworth, N.; Tyring, S.; Hercogova, J.; Bloch, M.; Davis, M.; Lewis, M.; Boutolleau, D.; Attali, P.; Bisshop, F.R.; Bloch, M.T.; Bodworth, N.J.; Aster, V.; Asterova, J.; Hercogova, J.; Klimesova, R.; Krajsova, I.; Ben Slama, L.; Cambazard, F.; Chosidow, O.; Dubertret, L.; Granel, F.; Humbert, P.; Ortonne, J.P.; Rostain, G.; Ruer-Mulard, M.; Vaillant, L.; Beiber, T.; Degen, A.J.; Dörzapf, O.; von Hake, G.; Miller, A.; Naudts, I.; Steinert, M.; Stockfleth, E.; Weihe, J.; Wunderlich, U.; Jasieniak-Pinis, G.; Kazina, M.; Pawlaczyk-Strugala, E.; Placek, W.; Petryka, R.; Romanowski, L.; Dixon, C.J.; Lewis, M.; Sharma, R.; Archuleta, M.; Baker, D.A.; Cady, R.K.; Conant, M.A.; Crump, W.L.; Davis, M.G.; Dunlap, F.E.; Lee 2014: Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial Journal of Drugs in Dermatology: Jdd 13(7): 791-798
Hese, R.T. 1992: Salivation test in patients with affective disorders treated with amitriptyline, mianserin and electroconvulsive therapy Psychiatria Polska 26(1-2): 29-36
James, N.M. 1975: A double blind trial of nitrazepam and flurazepam as sedatives New Zealand Medical Journal 81(535): 246-248
Végh, J. 1970: Clinical studies of a new analgesic in a double-blind trial Zeitschrift für Allgemeinmedizin 46(15): 795-799
Arthur, G.P.; Hornabrook, R.W. 1971: The treatment of migraine with BC 105 (pizotifen): a double blind trial New Zealand Medical Journal 73(464): 5-9
Simmer, K.; Lort-Phillips, L.; James, C.; Thompson, R.P. 1991: A double-blind trial of zinc supplementation in pregnancy European Journal of Clinical Nutrition 45(3): 139-144
Diamond, R.J. 1983: Outpatient use of a double-blind medication trial: a clinical example Journal of Clinical Psychiatry 44(8): 304-305